Christoph A Steffen

Suggest Changes
Learn More
INTRODUCTION An estimated one hundred million African meningitis belt residents have received MenAfriVac(®)meningococcal serogroup A conjugate vaccine. Since October 2012 the vaccine has been(More)
  • 1